Abstract:Background: Circulating tumor cells (CTCs) have long been considered a reflection of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a crucial step in the metastasis cascade, which leads ultimately to the formation of overt metastases. However, owing to the rarity of CTCs in peripheral blood, detecting these cells requires methods combined with high sensitivity and specificity, which sets tremendous challenges for the implementation of these assays into clinical routine. Methods: Generally, CTCs detection methods are composed of the following two steps: enrichment (isolation) process (morphological and immunological techniques) and detection (identification) process (cytometric and nucleic acid techniques), which may or may not be separate from enrichment. Genetic and molecular characterization of CTCs carried out by fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), PCR-based techniques, and biomarker immunofluorescent staining extract more information about malignant profile, metastatic potential of CTCs, and the extent to which CTCs are genetically identical to the primary tumor. Results: Recent technical advances made it possible to detect CTCs. The efficacy of circulating tumor cell (CTC) detection among patients with solid malignancy has been investigated, which shows great potential to become a tool for real-time parameter of prognosis and serve as an early marker to assess the therapeutic response in overt cancers. Improvements in detection and characterization of CTCs will hopefully lead to refinement of clinical management of cancer patients. Conclusion: This review addresses the majority of assays that have been published thus far, including the enrichment and detection steps and the markers used in these assays, accompanied by some biological issues of CTC and the results of clinical application harvested.

Circulating tumor cell detection kit and application thereof

Circulating tumor stem cell detection kit based on magnetic beads and microfluidic chip

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

Antibody-Functional Microspheres Integrated Filter Chip with Inertial Microflow for Size-Immune-Capturing and Digital Detection of Circulating Tumor Cells.

Circulating tumor cell capture and classification magnetism micro-fluidic chip as well as manufacturing method and using method thereof

Application of Microfluidics in Detection of Circulating Tumor Cells

Nano/Micro Fluidic Systems for Circulating Tumor Cells (ctcs) Rapid Detection and Diagnosis

Lung cancer CTCs (Circulating Tumor Cells) capturing and activity detection and analysis methods and application thereof

Design and Clinical Application of an Integrated Microfluidic Device for Circulating Tumor Cells Isolation and Single-Cell Analysis

All-in-One Microfluidic Chip for Online Labeling, Separating, and Focusing Rare Circulating Tumor Cells from Blood Samples Followed by Inductively Coupled Plasma Mass Spectrometry Detection

Real-time quantitative PCR detection of circulating tumor cells using tag DNA mediated signal amplification strategy

Biomimetic Microfluidic System for Fast and Specific Detection of Circulating Tumor Cells

Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications

Detection of circulating tumor cells: opportunities and challenges

Combination of microfluidic chips and biosensing for the enrichment of circulating tumor cells

High purity microfluidic sorting and in situ inactivation of circulating tumor cells based on multifunctional magnetic composites

Isolation and Retrieval of Circulating Tumor Cells on A Microchip with Double Parallel Layers of Herringbone Structure

Engineering Microfluidic Chip for Circulating Tumor Cells: from Enrichment, Release to Single Cell Analysis

Enrichment and Analysis of Circulating Tumor Cells by Integrating Multivalent Membrane Nano-Interface and Endogenous Enzyme-Signal Amplification